Vera Therapeutics Inc - Ordinary Shares - Class A
VERA
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.14B
Close$
$4.32
84.5% downside
Current Fair Value
84.5% downsideOvervalued by 84.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.14 Billion |
|---|---|
| Enterprise Value | $2.17 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4.66 |
| Beta | 0.95 |
| Outstanding Shares | 71,838,008 |
Return
| Return on Equity | -98.56% |
|---|---|
| Return on Assets | -75.40% |
| Return on Invested Capital | -82.98% |
Valuation & Multiples
| P/E Ratio | -5.1 |
|---|---|
| PEG | -11.85 |
| Price to Sales | - |
| Price to Book Ratio | 5.58 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -5.4 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.18 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 11, 2026
EPS Estimate
$-1.58
Average shareholder expectationRevenue Estimate
$1.28 M
Average shareholder expectationNext Earnings Call
Expected Date
November 4, 2026
EPS Estimate
$-1.61
Average shareholder expectationRevenue Estimate
$3.90 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 67.43% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.11%▼ 109.14% |
|---|---|
| Total Invested | $2.49M▼ 99.93% |
| Investors Holding | 6▼ 228.00% |
ESG Score
No data
About Vera Therapeutics Inc
19 employees